BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24879981)

  • 1. Drug-induced liver injury due to cancer chemotherapeutic agents.
    Bahirwani R; Reddy KR
    Semin Liver Dis; 2014 May; 34(2):162-71. PubMed ID: 24879981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of chemotherapeutic agents.
    Perry MC
    Semin Oncol; 1982 Mar; 9(1):65-74. PubMed ID: 7071610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic complications of chemotherapy. From trivial cytolysis to hepatic veno-occlusive disease].
    Baron F; Beguin Y
    Rev Med Liege; 1997 Feb; 52(2):93-7. PubMed ID: 9173491
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
    Reyes-Habito CM; Roh EK
    J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced hepatotoxicity.
    Thatishetty AV; Agresti N; O'Brien CB
    Clin Liver Dis; 2013 Nov; 17(4):671-86, ix-x. PubMed ID: 24099024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced hepatotoxicity in cancer patients - implication for treatment.
    Vincenzi B; Armento G; Spalato Ceruso M; Catania G; Leakos M; Santini D; Minotti G; Tonini G
    Expert Opin Drug Saf; 2016 Sep; 15(9):1219-38. PubMed ID: 27232067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy induced liver abnormalities: an imaging perspective.
    Sharma A; Houshyar R; Bhosale P; Choi JI; Gulati R; Lall C
    Clin Mol Hepatol; 2014 Sep; 20(3):317-26. PubMed ID: 25320738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of SAMe in chemotherapy-induced liver injury.
    Vincenzi B; Russo A; Terenzio A; Galvano A; Santini D; Vorini F; Antonelli-Incalzi R; Vespasiani-Gentilucci U; Tonini G
    Crit Rev Oncol Hematol; 2018 Oct; 130():70-77. PubMed ID: 30196914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic agents and the skin: An update.
    Heidary N; Naik H; Burgin S
    J Am Acad Dermatol; 2008 Apr; 58(4):545-70. PubMed ID: 18342708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypersensitivity reactions to chemotherapeutic antineoplastic agents].
    Rossi F; Incorvaia C; Mauro M
    Recenti Prog Med; 2004 Oct; 95(10):476-81. PubMed ID: 15560295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma.
    Chung CG; Poligone B
    Dermatol Clin; 2015 Oct; 33(4):787-805. PubMed ID: 26433850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxic effects of oncotherapeutic agents.
    Zimmerman HJ
    Prog Liver Dis; 1986; 8():621-42. PubMed ID: 3520672
    [No Abstract]   [Full Text] [Related]  

  • 15. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes.
    McWhirter D; Kitteringham N; Jones RP; Malik H; Park K; Palmer D
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):404-15. PubMed ID: 23786843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.
    Alessandrino F; Tirumani SH; Krajewski KM; Shinagare AB; Jagannathan JP; Ramaiya NH; Di Salvo DN
    Clin Radiol; 2017 Jul; 72(7):521-533. PubMed ID: 28476244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?
    Maniecki MB; Hasle H; Bendix K; Møller HJ
    Leuk Res; 2011 Jun; 35(6):e84-6. PubMed ID: 21329979
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer chemotherapy I: hepatocellular injury.
    Rodriguez-Frias EA; Lee WM
    Clin Liver Dis; 2007 Aug; 11(3):641-62, viii. PubMed ID: 17723924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
    Kleiner DE
    Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.